FDA Warns Public About Recall of Polyfort Suspension in Nigeria

The Food and Drugs Authority (FDA) has issued a warning to the public about the immediate recall of all batches of Polyfort Suspension in Nigeria. The suspension is manufactured by Swiss Pharma Limited and is used for the treatment of heartburn, indigestion, and hyperacidity. The recall is due to negative results from a series of ongoing stability tests.

As a neighboring country, the FDA has cautioned citizens to be alert and cautious of the drugs they consume. The FDA Ghana has not registered the product, but anyone who comes across it in trade in Ghana should report to any of the FDA’s offices across the country.

The FDA’s surveillance team is actively monitoring the country’s ports of entry and markets to ensure that unregistered products like the Polyfort Suspension are not available in the country. The FDA advised the public to check the registration status of regulated products from its website or through the ProPer platform before purchase.

The recall of the Polyfort Suspension in Nigeria is a crucial reminder of the importance of rigorous safety testing and quality control for all drugs manufactured and sold in the country. While the Ghanaian FDA has not registered the product, it is essential to remain vigilant and cautious about the drugs consumed to ensure safety.

Consumers must check the labels of any medication before purchasing and should only buy drugs from reputable pharmacies or retailers. They should also report any suspected counterfeit or unregistered drugs to the appropriate regulatory authorities.

For the most part, the FDA is working hard to ensure that drugs and other medical products available to the public are safe and effective. It is also crucial that the public plays a role in ensuring that they only consume regulated drugs and report any suspicious products.

In a nutshell, the recall of the Polyfort Suspension in Nigeria highlights the importance of ongoing safety testing and quality control in the drug manufacturing process. It is essential to remain vigilant and cautious about the drugs consumed to ensure the safety and health of all.